Sustainable Drug Discovery and Development with End-of-Life Yield

Description of the granted funding

The ecological risks related to pharmaceutical emissions are an increasing concern both locally and globally. Hormonal and antibiotic residues are particularly harmful even at very low concentrations. Current societal transformations incl. urbanization, population growth and ageing, contribute to the accumulation of pharmaceuticals in the environment at an accelerated pace. The SUDDEN project tackles the environmental hazards and sustainability challenges related to drug manufacturing, consumption, and end-of-life. The project aims to enhance the benign-by-design drug discovery, bridge the gaps in the legal framework of global production chains of pharmaceuticals, redesign modern wastewater purification and reuse of the sewage sludge, and introduce circular economy models to pharmaceutical packaging materials with a view to developing a Life Cycle Impact Assessment model to drug products and supporting the economic growth of sustainable pharmaceutical industry and services in Finland.
Show more

Starting year

2022

End year

2023

Granted funding

Mika Mänttäri Orcid -palvelun logo
210 951 €






Role in consortium of the Academy of Finland

Partner

Other consortium parties

Partner
Aalto University (346570)
175 662 €
Partner
University of Eastern Finland (346571)
350 325 €
Partner
Finnish Environment Institute (346572)
176 233 €
Partner
(346573)
170 444 €
Leader
University of Helsinki (346568)
750 473 €

Funder

Research Council of Finland

Funding instrument

Strategic Research Funding

Decision maker

Strategic Research Council
13.09.2021

Other information

Funding decision number

346569

Fields of science

Pharmacy

Research fields

Farmasia

Themes

Uudistu tai surkastu - resurssit ja ratkaisut

Identified topics

public health, occupational health